We argue that predictability (how well spending on certain services can be anticipated) and predictiveness (how well certain services contemporaneously co-vary with total health care spending) both matter for understanding adverse selection incentives. Three main points are made. First, the predictability of specific services rather than of total spending matters for problems of adverse selection. Second, it is generally what the plan (not the individual) predicts that matters, since it is the plan (not the individual) that chooses actions such as excluding applicants or distorting services, which create adverse selection. Third, among those services that are predictable, health plans have incentives to underprovide those that are positivel...
To investigate the extent of favorable health maintenance organization (HMO) selection for a longitu...
This dissertation addresses the issues of adverse selection in the health insurance market. The lite...
The growth of pharmaceutical expenditure and its prediction is a major concern for policy makers and...
This paper re-examines the relation between the predictability of health care spending and incentive...
Health plans paid by capitation have an incentive to distort the quality of services they offer to a...
To determine the extent to which people make choices inconsistent with expected utility theory when ...
The authors assess how Medicare financing and projections of future costs have changed since 2000. T...
This paper quantifies risk selection among competing Medicare managed care plans, using beneficiary ...
This paper investigates a possible predictor of adverse selection problems in unsubsidized stand-alo...
Objective. Numerous electronic tools help consumers select health insurance plans based on their est...
Objectives: To test the hypothesis that the "severity effect"-the preference for more than utility-m...
Most health care evaluations today still assume expected utility even though the descriptive deficie...
2017 © The Authors. That one-quarter of Medicare spending in the United States occurs in the last ye...
Health care expenditures as a percentage of GDP have grown at an alarming rate in developed countrie...
We provide strong evidence of advantageous selection in the Medigap insurance market, and analyze it...
To investigate the extent of favorable health maintenance organization (HMO) selection for a longitu...
This dissertation addresses the issues of adverse selection in the health insurance market. The lite...
The growth of pharmaceutical expenditure and its prediction is a major concern for policy makers and...
This paper re-examines the relation between the predictability of health care spending and incentive...
Health plans paid by capitation have an incentive to distort the quality of services they offer to a...
To determine the extent to which people make choices inconsistent with expected utility theory when ...
The authors assess how Medicare financing and projections of future costs have changed since 2000. T...
This paper quantifies risk selection among competing Medicare managed care plans, using beneficiary ...
This paper investigates a possible predictor of adverse selection problems in unsubsidized stand-alo...
Objective. Numerous electronic tools help consumers select health insurance plans based on their est...
Objectives: To test the hypothesis that the "severity effect"-the preference for more than utility-m...
Most health care evaluations today still assume expected utility even though the descriptive deficie...
2017 © The Authors. That one-quarter of Medicare spending in the United States occurs in the last ye...
Health care expenditures as a percentage of GDP have grown at an alarming rate in developed countrie...
We provide strong evidence of advantageous selection in the Medigap insurance market, and analyze it...
To investigate the extent of favorable health maintenance organization (HMO) selection for a longitu...
This dissertation addresses the issues of adverse selection in the health insurance market. The lite...
The growth of pharmaceutical expenditure and its prediction is a major concern for policy makers and...